ArticleSleep & breathing = Schlaf & Atmung2009
Elevated economic burden in obstructive lung disease patients with concomitant sleep apnea syndrome.
Article in Sleep & breathing = Schlaf & Atmung, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
27 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- The Impact of Different Mobile Health Technologies on Physical Activity of COPD Patients: A Systematic Review and Network Meta-Analysis.Journal of medical systems · 2025Pooled it
- Excess costs of comorbidities in chronic obstructive pulmonary disease: a systematic review.PloS one · 2015Pooled it
- Effect of lung function on the apnea-hypopnea index in patients with overlap syndrome: a multicenter cross-sectional study.Sleep & breathing = Schlaf & Atmung · 2020Trial
- Effect of lung volume on the apnea hypopnea index in patients with overlap syndrome: a single center study.Sleep & breathing = Schlaf & Atmung · 2026Article
- Investigating the Incremental Cost and Utilization Burden of Obstructive Sleep Apnea in Overweight to Severely Obese Patients.Diabetes, obesity & metabolism · 2026Article
- The Risk Factors and Predictors of Chronic Obstructive Pulmonary Disease in Patients With Obstructive Sleep Apnea-Hypopnea Syndrome at Plateau.The clinical respiratory journal · 2025Article
- Effect of compliance to continuous positive airway pressure on exacerbations, lung function and symptoms in patients with chronic obstructive pulmonary disease and obstructive sleep apnea (overlap syndrome).The clinical respiratory journal · 2023Article
- Review of the prevalence, pathogenesis and management of OSA-COPD overlap.Sleep & breathing = Schlaf & Atmung · 2022Review
- OSA and Chronic Respiratory Disease: Mechanisms and Epidemiology.International journal of environmental research and public health · 2022Review
- Burden of Comorbidities in Patients with OSAS and COPD-OSAS Overlap Syndrome.Medicina (Kaunas, Lithuania) · 2021Article
- Determining the prevalence of symptoms and risk of obstructive sleep apnoea among old Saudis.Journal of Taibah University Medical Sciences · 2021Article
- The Economic Burden of Comorbid Obstructive Sleep Apnea Among Patients with Chronic Obstructive Pulmonary Disease.Journal of managed care & specialty pharmacy · 2020Article
- Article
- The Bronchiectasis in COPD-OSA Overlap Syndrome Patients.International journal of chronic obstructive pulmonary disease · 2020Article
- Direct and indirect costs of COPD progression and its comorbidities in a structured disease management program: results from the LQ-DMP study.Respiratory research · 2019Article
- Daytime loop gain is elevated in obstructive sleep apnea but not reduced by CPAP treatment.Journal of applied physiology (Bethesda, Md. : 1985) · 2018Article
- To sleep, or not to sleep - that is the question, for polysomnography.Breathe (Sheffield, England) · 2017Article
- Recognition and treatment of sleep-disordered breathing: an important component of chronic disease management.Journal of translational medicine · 2017Review
- Influence of Lung Function and Sleep-disordered Breathing on All-Cause Mortality. A Community-based Study.American journal of respiratory and critical care medicine · 2016Article
- Clinical factors and comorbidities affecting the cost of hospital-treated COPD.International journal of chronic obstructive pulmonary disease · 2016Article
Corrections and comments
- Commented on by
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThe purpose of this study is to examine the incremental economic burden of sleep apnea syndrome (SAS) among individuals with concomitant asthma, chronic obstructive pulmonary disease (COPD), or both (i.e., asthma/COPD).
methodsMaryland Medicaid claims data were used to identify beneficiaries with asthma (n = 3,072), COPD (n = 3,455), or both (n = 2,604). We compared patient's baseline characteristics by SAS and stratified the analyses by disease cohort to examine the effect of SAS on medical utilization and cost.
resultsSAS was more prevalent among beneficiaries with asthma/COPD (6.72%) than beneficiaries with COPD alone (2.87%) or asthma alone (2.15%). Asthma/COPD and COPD beneficiaries with SAS had more medical service claims (p < 0.001) and higher medical cost than beneficiaries without SAS: $5,773 and $4,155 in excess costs among asthma/COPD (p = 0.037) and COPD patients (p = 0.035), respectively. Medical utilization and cost did not differ by SAS in asthma patients (p = 0.567).
conclusionsSAS may add additional economic burden on beneficiaries who already have COPD or asthma/COPD.
Indexed as
Identifiers
19484281What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.